Antimicrobial Agents Practice Questions

Q: Mechanism of action of Oseltamivir?

Neuraminidase inhibitor. ***Neuraminidase inhibitor*** - **Oseltamivir** prevents the release of new influenza virus particles from infected cells by inhibiting **neuraminidase**, an enzyme essential for viral replication. - This inhibition limits the spread of the virus to uninfected cells, thereby reducing the severity and duration of the **flu**. *Inhibitor of protein synthesis* - This mechanism is characteristic of certain **antibiotics** (e.g., tetracyclines, macrolides) or **antitumor agents**, not antiviral medications like oseltamivir. - Inhibiting protein synthesis would interfere with the host cell's vital functions and is not the primary target for influenza antivirals. *Inhibitor of thymidylate synthetase* - **Thymidylate synthetase inhibitors** (e.g., 5-fluorouracil) are primarily used in **cancer chemotherapy** to block DNA synthesis in rapidly dividing cells. - This mechanism is not relevant to the action of oseltamivir against influenza virus. *Pyrimidine analogs* - **Pyrimidine analogs** (e.g., zidovudine, fluorouracil) are drugs that mimic natural pyrimidine bases and interfere with nucleic acid synthesis. - While some antivirals act as nucleoside/nucleotide analogs, this is a broader category, and oseltamivir's specific action is not as a pyrimidine analog.

Q: What is the drug of choice for treating isosporiasis?

Co-trimoxazole. ***Co-trimoxazole*** - **Co-trimoxazole** (trimethoprim-sulfamethoxazole) is the **drug of choice** for treating **isosporiasis** (*Cystoisospora belli*, formerly *Isospora belli*), particularly in both immunocompetent and immunocompromised individuals. - Its mechanism of action involves inhibiting **folic acid synthesis** in the parasite through sequential blockade of the folate pathway, leading to its death. - Standard dose: **TMP 160 mg/SMX 800 mg QID for 10 days** in immunocompetent patients; HIV patients may require longer therapy and secondary prophylaxis. *Penicillin G* - **Penicillin G** is an **antibiotic** primarily used to treat bacterial infections, such as those caused by Streptococcus and Staphylococcus species. - It has **no activity** against **Isospora belli**, which is a parasitic protozoan infection. *Benzathine penicillin* - **Benzathine penicillin** is a **long-acting form of penicillin** commonly used for syphilis and rheumatic fever prevention due to its prolonged release. - Like penicillin G, it is an antibacterial agent and is **ineffective against parasitic infections** like isosporiasis. *Albendazole* - **Albendazole** is an **antihelminthic drug** used to treat a variety of helminth infections, such as hookworm, roundworm, and tapeworm. - It is **not effective** against **Isospora belli**, which is a protozoan parasite, not a helminth.

Q: What is the primary site of action of amphotericin B?

Plasma membrane. ***Plasma membrane*** - Amphotericin B primarily acts at the **fungal cell membrane**, specifically by binding to **ergosterol**, a sterol essential for fungal membrane integrity. - This binding leads to the formation of **pores** or channels in the membrane, causing leakage of intracellular ions and macromolecules, thus disrupting cellular function and causing cell death. *Cell wall* - The **cell wall** is mainly composed of **chitin** and glucans, which provide structural rigidity to fungal cells. - Amphotericin B does not directly target the fungal cell wall; instead, its action is focused on the underlying **plasma membrane**. *Protein* - Amphotericin B is a **polyene antifungal** medication and is not primarily involved in targeting or inhibiting protein synthesis. - Inhibition of **protein synthesis** is a mechanism seen in certain antibacterial agents (e.g., tetracyclines, macrolides) but not in amphotericin B. *Ribosomes* - **Ribosomes** are responsible for protein synthesis and are not the primary target of amphotericin B. - While disrupting the cell membrane can indirectly affect various cellular processes, including protein synthesis, it is not a direct site of action for this drug.

Q: What is the drug of choice for treating Cyclosporiasis?

Trimethoprim-sulfamethoxazole combination. ***Trimethoprim-sulfamethoxazole combination*** - **Trimethoprim-sulfamethoxazole (TMP-SMX)** is the highly effective and **drug of choice** for treating **Cyclosporiasis**, particularly in both immunocompetent and immunocompromised individuals. - It is administered orally and works by inhibiting folic acid synthesis in the parasite. *Paromomycin* - **Paromomycin** is an aminoglycoside antibiotic primarily used for treating intestinal amebiasis and cryptosporidiosis, but it is **not effective** against Cyclosporiasis. - It exhibits poor systemic absorption and thus primarily acts within the gastrointestinal tract. *Metronidazole* - **Metronidazole** is commonly used to treat infections caused by anaerobic bacteria and certain parasites like *Giardia* and *Entamoeba histolytica*, but it is **ineffective** against *Cyclospora cayetanensis*. - Its mechanism of action involves disrupting DNA and protein synthesis in susceptible organisms. *Cyclosporin* - **Cyclosporin** is an immunosuppressant drug used to prevent organ transplant rejection and treat autoimmune diseases, and it has **no antiparasitic activity** against *Cyclospora*. - Its primary function is to inhibit T-lymphocyte activation.

Q: Carbapenem which has a tendency to cause maximum seizures?

Imipenem. ***Imipenem*** - **Imipenem** is associated with the highest risk of **seizures** among the carbapenems, particularly in patients with **renal impairment**, pre-existing **CNS disorders**, or high doses. - Its high affinity for **GABA-A receptors** in the central nervous system is thought to contribute to its proconvulsant effects. *Ertapenem* - While all carbapenems carry some risk of seizures, **ertapenem** has a **lower incidence** compared to imipenem. - It is often favored in patients without CNS infections or severe renal dysfunction due to its once-daily dosing. *Doripenem* - **Doripenem** also has a relatively **low risk of seizures** compared to imipenem. - It is generally well-tolerated, with side effects similar to other carbapenems but at a reduced frequency for CNS events. *Meropenem* - **Meropenem** is known to have a **lower seizure potential** than imipenem, making it a preferred choice for patients with a history of seizures or those with CNS infections. - Its **reduced affinity** for GABA-A receptors contributes to its better CNS tolerability.

Q: Which fluoroquinolone has the maximum bioavailability?

Levofloxacin. ***Levofloxacin*** - **Levofloxacin** exhibits high oral bioavailability, approximately 99%, meaning nearly all of the administered dose reaches systemic circulation [1]. - This high bioavailability allows for seamless transition from intravenous to oral administration without significant changes in drug exposure [1]. *Moxifloxacin* - **Moxifloxacin** has a high bioavailability of approximately 90%, which is slightly lower than levofloxacin's almost complete absorption [1]. - While excellent, it is not the absolute highest among fluoroquinolones. *Gatifloxacin* - **Gatifloxacin** has good oral bioavailability, around 96%, but it is still generally considered slightly less than that of levofloxacin [1]. - This difference, though small, makes levofloxacin the one with the highest overall bioavailability. *Ciprofloxacin* - **Ciprofloxacin** has the lowest oral bioavailability among the listed fluoroquinolones, ranging from 70% to 80% [1]. - Its absorption can be significantly impaired by co-administration with multivalent cations, leading to reduced systemic concentrations.

Q: Which antiretroviral drug also has anti-hepatitis activity?

Tenofovir. ***Tenofovir*** - **Tenofovir** is a nucleotide reverse transcriptase inhibitor (NtRTI) that is highly effective against both **HIV** and **Hepatitis B virus (HBV)**. - It is a **first-line agent** for HBV treatment with a **high barrier to resistance**, making it the preferred choice for dual therapy in HIV/HBV coinfection. - It is FDA-approved for both HIV and HBV treatment and is a key component in antiretroviral therapy (ART) regimens for coinfected patients. *Abacavir* - **Abacavir** is a nucleoside reverse transcriptase inhibitor (NRTI) used for HIV treatment. - It does not have significant activity against **Hepatitis B virus (HBV)** or other hepatitis viruses. *Emtricitabine* - **Emtricitabine** is a nucleoside reverse transcriptase inhibitor (NRTI) that has activity against both **HIV** and **HBV**. - While it is FDA-approved for HBV treatment, it has a **lower barrier to resistance** compared to tenofovir and is less preferred as monotherapy for HBV. - It is commonly used in combination with tenofovir (as in Truvada) for enhanced efficacy in HIV/HBV coinfection. - **Tenofovir remains the best answer** due to its superior resistance profile and status as first-line HBV therapy. *Nevirapine* - **Nevirapine** is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used specifically for **HIV infection**. - It does not demonstrate antiviral activity against **Hepatitis B virus (HBV)** or other forms of viral hepatitis.

Q: What is the drug of choice (DOC) for the treatment of subacute sclerosing panencephalitis (SSPE)?

Inosine pranobex. ***Inosine pranobex*** - **Inosine pranobex (Isoprinosine)** is considered the **oral drug of choice** for treating **subacute sclerosing panencephalitis (SSPE)**, particularly in the early stages, as it has shown success in delaying disease progression. - This drug works by **modulating the immune system** and enhancing T-cell function, which helps control the persistent measles virus infection in the CNS. - **Note:** Best outcomes are achieved when inosine pranobex is combined with **intrathecal/intraventricular interferon-alpha**, but as a single oral agent, inosine pranobex is the primary choice. *Abacavir* - **Abacavir** is an **antiretroviral drug (NRTI)** used in the treatment of **HIV infection**. - It inhibits reverse transcriptase and has **no role** in treating measles virus-induced SSPE. *Glatiramer* - **Glatiramer acetate** is an **immunomodulatory drug** used in **multiple sclerosis (MS)**. - It works by mimicking **myelin basic protein** to reduce immune attacks on myelin, but is **not effective** against viral infections like SSPE. *Interferon* - **Interferon-alpha** (particularly **intrathecal/intraventricular** administration) has been used in **SSPE** as **combination therapy** with inosine pranobex, showing improved outcomes. - However, when given systemically alone, it has **significant side effects** and **variable efficacy**. - As a single answer option without specifying the route, **inosine pranobex** is preferred as the primary oral DOC.

Q: Which of the following medications is not indicated for the treatment or prophylaxis of seasonal influenza?

Acyclovir. ***Acyclovir*** - **Acyclovir** is an antiviral medication specifically used to treat infections caused by **herpes viruses** (e.g., HSV, VZV), not influenza viruses. - It works by inhibiting **viral DNA polymerase**, a mechanism distinct from how anti-influenza drugs act. - **This drug has never been indicated for influenza** - it is the correct answer to this "not indicated" question. *Amantadine* - **Amantadine** is an M2 ion channel inhibitor that **was indicated** for influenza A treatment and prophylaxis. - Although no longer recommended due to widespread **resistance** among circulating influenza strains, it remains a drug that was formally indicated for seasonal influenza. *Rimantadine* - **Rimantadine** is also an M2 ion channel inhibitor, structurally related to amantadine, with a similar mechanism of action. - Like amantadine, it **was indicated** for influenza treatment or prophylaxis but is no longer recommended due to high rates of **resistance** in circulating influenza A viruses. *Oseltamivir* - **Oseltamivir** is a **neuraminidase inhibitor** currently approved and recommended for the treatment and prophylaxis of both influenza A and B. - It reduces viral spread by preventing the release of new virions from infected cells and remains a first-line agent for seasonal influenza.

Question 1

Mechanism of action of Oseltamivir?

Accepted Answer

Neuraminidase inhibitor

Answer

Inhibitor of protein synthesis

Answer

Inhibitor of thymidylate synthetase

Answer

Pyrimidine analogs

Question 2

What is the drug of choice for treating isosporiasis?

Accepted Answer

Co-trimoxazole

Answer

Penicillin G

Answer

Benzathine penicillin

Answer

Albendazole

Question 3

What is the primary site of action of amphotericin B?

Accepted Answer

Plasma membrane

Answer

Cell wall

Answer

Protein

Answer

Ribosomes

Question 4

Imipenem, a newer antibiotic with a broad antibacterial spectrum, is co-administered with cilastatin. What is the primary reason for this combination?

Accepted Answer

Cilastatin prevents the degradation of imipenem by inhibiting an enzyme in the kidneys.

Answer

Cilastatin enhances the gastrointestinal absorption of imipenem.

Answer

Cilastatin inhibits the beta-lactamase enzyme that degrades imipenem.

Answer

The combination of antibiotics is synergistic against Pseudomonas species.

Question 5

What is the drug of choice for treating Cyclosporiasis?

Accepted Answer

Trimethoprim-sulfamethoxazole combination

Answer

Paromomycin

Answer

Metronidazole

Answer

Cyclosporin

Question 6

Carbapenem which has a tendency to cause maximum seizures?

Accepted Answer

Imipenem

Answer

Ertapenem

Answer

Doripenem

Answer

Meropenem

Question 7

Which fluoroquinolone has the maximum bioavailability?

Accepted Answer

Levofloxacin

Answer

Gatifloxacin

Answer

Ciprofloxacin

Answer

Moxifloxacin

Question 8

Which antiretroviral drug also has anti-hepatitis activity?

Accepted Answer

Tenofovir

Answer

Abacavir

Answer

Nevirapine

Answer

Emtricitabine

Question 9

What is the drug of choice (DOC) for the treatment of subacute sclerosing panencephalitis (SSPE)?

Accepted Answer

Inosine pranobex

Answer

Abacavir

Answer

Glatiramer

Answer

Interferon

Question 10

Which of the following medications is not indicated for the treatment or prophylaxis of seasonal influenza?

Accepted Answer

Acyclovir

Answer

Amantadine

Answer

Rimantadine

Answer

Oseltamivir

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?